You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TAM

Showing 1 - 25 of 832
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melasma Trial in Karachi (TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C), Kligman formula (hydroquinone 4%,

Active, not recruiting
  • Melasma
  • TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C)
  • Kligman formula (hydroquinone 4%, fluocinolone acetonide 0.01% and tretinoin 0.05%)
  • Karachi, Sindh, Pakistan
    JPMC
Aug 25, 2023

The Antiaggregation Monitoring (TAM) Registry

Completed
  • Aspirin Causing Adverse Effects in Therapeutic Use
  • Measurement of platelet anti-aggregation
  • Fribourg, FR, Switzerland
    Service de Cardiologie, Hôpital Cantonal Fribourg
Oct 14, 2021

Endometrial Changes in Breast Cancer Women.

Active, not recruiting
  • Endometrial Cancer
  • +3 more
  • Hysteroscopy
  • Rome, Lazio, Italy
    IRCCS "Regina Elena" National Cancer Institute
Jan 29, 2023

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Alpelisib, Tamoxifen, Infigratinib)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Stanford, California
    Stanford University
Nov 16, 2022

RWE About QOL and Compliance of Patients With OFS in China

Not yet recruiting
  • Breast Cancer
  • +2 more
  • 3M GnRHa
  • 1M GnRHa
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 15, 2021

Voice Change, Hypocalcemia Trial (Dexamethasone, Normal saline)

Not yet recruiting
  • Voice Change
  • Hypocalcemia
  • (no location specified)
Feb 8, 2023

Visual Acuity Trial in United States (ACUVUE OASYS® 1-Day for Astigmatism - TAM 24, ACUVUE OASYS® 1-Day for Astigmatism)

Completed
Has Results
  • Visual Acuity
  • ACUVUE OASYS® 1-Day for Astigmatism - TAM 24
  • ACUVUE OASYS® 1-Day for Astigmatism
  • Longwood, Florida
  • +4 more
Apr 27, 2022

Non Metastatic Breast Cancer Trial in Lyon, Paris, Saint Herblain (tamoxifen)

Completed
  • Non Metastatic Breast Cancer
  • Lyon, France
  • +2 more
Mar 10, 2021

Leuprorelin 3M in Premenopausal Hormone Receptor-positive Breast

Not yet recruiting
  • Hormone Receptor-positive Breast Cancer
  • AI or TAM
  • (no location specified)
May 17, 2021

Transplant Associated Microangiopathy TAM Trial in France, Germany, United States (LFG316 active drug, Standard of care

Terminated
Has Results
  • Transplant Associated Microangiopathy TAM
  • LFG316 active drug
  • Standard of care treatment
  • Chapel Hill, North Carolina
  • +5 more
Dec 9, 2020

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

Tuberculosis Trial in Worldwide (FLOW-TB Next-generation LAM, TAM-TB, Host Response Cartridge)

Recruiting
  • Tuberculosis
  • FLOW-TB Next-generation LAM
  • +13 more
  • Vellore, India
  • +10 more
Dec 8, 2022

X Linked Myotubular Myopathy Trial in Canada, United Kingdom, United States (ApoTamox 10mg, Placebo)

Recruiting
  • X Linked Myotubular Myopathy
  • ApoTamox 10mg
  • Placebo
  • Chicago, Illinois
  • +3 more
Jun 17, 2021

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Duchenne Muscular Dystrophy Trial in Worldwide (Tamoxifen, Matching )

Completed
  • Duchenne Muscular Dystrophy
  • Garches, France
  • +10 more
Dec 19, 2022

"Don't Eat me" Signal in Hematological Malignancies: CD24 as New

Recruiting
  • Mantle-cell Lymphoma
  • B Cell Chronic Lymphocytic Leukemia
    • Monza, MB, Italy
      Andrea Aroldi
    May 24, 2023

    Pregnancy Related Trial in New Taipei City (Decision aid)

    Completed
    • Pregnancy Related
    • Decision aid
    • New Taipei City, Taiwan
      Ka-Wai Tam
    Mar 16, 2020

    Neutrophil Extracellular Traps Formation in Breast Cancer

    Recruiting
    • Breast Carcinoma
    • Biospecimen Collection
    • Electronic Health Record Review
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2022

    Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive Trial in United States (Afimoxifene, Laboratory Biomarker Analysis,

    Recruiting
    • Ductal Breast Carcinoma In Situ
    • Estrogen Receptor Positive
    • Chicago, Illinois
    • +5 more
    Dec 17, 2020

    Desmoid Tumor Trial in Monrovia (tamoxifen citrate, sulindac, laboratory biomarker analysis)

    Completed
    Has Results
    • Desmoid Tumor
    • tamoxifen citrate
    • +2 more
    • Monrovia, California
      Children's Oncology Group
    Feb 7, 2020

    CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective

    Recruiting
    • Breast Cancer
    • +2 more
      • Erlangen, Germany
        Department of Gynecology and Obstetrics, Erlangen University Hos
      May 12, 2023

      Depression, Anxiety, Stress, Psychological Trial in Irvine (C-STRESS)

      Completed
      • Depression
      • +3 more
      • C-STRESS
      • Irvine, California
        UCI
      Mar 9, 2023

      Endometrial Malignancy in Breast Cancer or Without AUB

      Completed
      • Endometrial Neoplasms
      • Ultrasound
      • Hysteroscopy
      • Bologna, Italy
      • +3 more
      Aug 3, 2023

      Intent to UseTool With Regard to Symptom Management

      Not yet recruiting
      • Palliative Medicine
      • Survey
      • Groningen, Netherlands
      • +1 more
      Oct 24, 2023

      Opioid Use Trial in Brighton (Music Treatment)

      Recruiting
      • Opioid Use
      • Music Treatment
      • Brighton, Massachusetts
        Steward St. Elizabeth medical Center
      Dec 21, 2022